CN110302293A - A kind of externally applied drug that can effectively treat pressure sore - Google Patents
A kind of externally applied drug that can effectively treat pressure sore Download PDFInfo
- Publication number
- CN110302293A CN110302293A CN201910675453.7A CN201910675453A CN110302293A CN 110302293 A CN110302293 A CN 110302293A CN 201910675453 A CN201910675453 A CN 201910675453A CN 110302293 A CN110302293 A CN 110302293A
- Authority
- CN
- China
- Prior art keywords
- parts
- pressure sore
- externally applied
- effectively treat
- applied drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Chinese materia medica preparation, i.e., a kind of externally applied drug that can effectively treat pressure sore.It is made of following weight bulk pharmaceutical chemicals and auxiliary material: 0.5-3 parts of Radix Salviae Miltiorrhizae, 0.5-3 parts of dragon's blood, 0.5-3 parts of myrrh, 0.5-3 parts of olibanum, 0.5-3 parts of safflower;0.5-2 parts of the coptis, 0.5-2 parts of cordate houttuynia, 0.5-2 parts of Fructus Forsythiae, 0.5-2 parts of honeysuckle, 0.5-2 parts of dandelion, 0.5-2 parts of frutus cnidii, 0.5-2 parts of corydalis tuber, 0.1-1 parts of borneol, 0.5-2 parts of leech, 0.1-1 parts of cuttlebone, 0.1-1 parts of ginseng, 0.1-1 parts of Radix Astragali, 0.1-1 parts of gypsum.With activating microcirculation and removing stasis medicinal, analgesic therapy hemostasis, hold back creation flesh, clearing heat and detoxicating effect.Cure mainly pressure sore.By clinical observation, except corruption, detumescence, myogenic, more skin are fast.
Description
Technical field
The present invention relates to the field of Chinese medicines, i.e., a kind of externally applied drug that can effectively treat pressure sore.
Background technique
In the prior art, pressure sore is also known as pressure ulcer, bedsore, is that patient's long-term bed causes human local tissue long
Phase is pressurized, routinely ischemic, anoxic, malnutrition and cause tissue fester downright bad.The easy secondary infection of pressure sore causes skin broken
It bursts, fester, septicemia can be also caused as deep as bone, serious person and threat to life.Pressure sore has Chinese medicine treatment, but prescription is each
Different, curative effect is different.
Summary of the invention
The purpose of the present invention is provide a kind of externally applied drug that can effectively treat pressure sore significant in efficacy in view of the above deficiencies.
The technical solution of the invention is as follows: a kind of externally applied drug that can effectively treat pressure sore, it is characterised in that its is medicinal to have
Effect ingredient is made of the bulk pharmaceutical chemicals of following parts by weight: 0.5-3 parts of Radix Salviae Miltiorrhizae, 0.5-3 parts of dragon's blood, 0.5-3 parts of myrrh, olibanum 0.5-
3 parts, 0.5-3 parts of safflower;0.5-2 parts of the coptis, 0.5-2 parts of cordate houttuynia, 0.5-2 parts of Fructus Forsythiae, 0.5-2 parts of honeysuckle, dandelion
0.5-2 parts, 0.5-2 parts of frutus cnidii, 0.5-2 parts of corydalis tuber, 0.1-1 parts of borneol, 0.5-2 parts of leech, 0.1-1 parts of cuttlebone, ginseng
0.1-1 parts, 0.1-1 parts of Radix Astragali, 0.1-1 parts of gypsum.
It is preferred that a kind of externally applied drug that can effectively treat pressure sore, it is characterised in that be made of the bulk pharmaceutical chemicals of following parts by weight:
3 parts of Radix Salviae Miltiorrhizae, 3 parts of dragon's blood, 3 parts of myrrh, 3 parts of olibanum, 3 parts of safflower;1 part of the coptis, 1 part of cordate houttuynia, 1 part of Fructus Forsythiae, 1 part of honeysuckle,
1 part of dandelion, 1 part of frutus cnidii, 1 part of corydalis tuber, 0.5 part of borneol, 1 part of leech, 0.5 part of cuttlebone, 0.5 part of ginseng, Radix Astragali 0.5
Part, 0.5 part of gypsum.Pharmaceutically acceptable auxiliary material can also be contained.
Using activating microcirculation and removing stasis medicinal, analgesic therapy hemostasis, the Radix Salviae Miltiorrhizae for holding back creation flesh, dragon's blood, myrrh, olibanum, safflower as monarch drug in a prescription;It is dry with heat-clearing
Wet, purging fire for removing toxin the coptis, cordate houttuynia, Fructus Forsythiae, honeysuckle, dandelion are ministerial drug;Frutus cnidii, corydalis tuber, borneol, leech, sea Piao
Octopus, ginseng, Radix Astragali are adjutant;The effect of gypsum is to make medicine, plays activating microcirculation and removing stasis medicinal, analgesic therapy hemostasis altogether, holds back creation flesh, is clearing heat and detoxicating
Preparation method: according to modern Chinese herbal medicine preparation method, matching in proportion, and the raw material made is crushed, is screened to 200 mesh, is made into
Product (such as sterilize).
Function with the major functions: have activating microcirculation and removing stasis medicinal, analgesic therapy hemostasis, hold back creation flesh, clearing heat and detoxicating effect.Cure mainly pressure sore.
Usage: 1:10 is mixed with physiological saline, and medicine yarn is made and spreads on affected part, and one time a day, 7 days effective.
Pharmaceutical dosage form is without being limited thereto, by common pharmaceutical carrier, such as figuration on above-mentioned each medicinal raw material and pharmacy (pharmacy)
Agent or acceptable auxiliary material can be mixed and made into paste, patch or other conventional formulations.
The invention has the advantages that 1, pure Chinese medicinal preparation, prescription is more scientific, has activating microcirculation and removing stasis medicinal, analgesic therapy hemostasis, holds back creation
Flesh, clearing heat and detoxicating effect, improve therapeutic effect.2, it is used through clinical patients, 7 days effective, can effectively shorten the course of disease.
Embodiments of the present invention are described in further detail below in conjunction with embodiment.
Specific embodiment
Embodiment 1
A kind of externally applied drug that can effectively treat pressure sore, it is characterised in that its effective medicinal components by following parts by weight bulk pharmaceutical chemicals
It is made: 3 parts of Radix Salviae Miltiorrhizae, 3 parts of dragon's blood, 3 parts of myrrh, 3 parts of olibanum, 3 parts of safflower;1 part of the coptis, 1 part of cordate houttuynia, 1 part of Fructus Forsythiae, honeysuckle
1 part, 1 part of dandelion, 1 part of frutus cnidii, 1 part of corydalis tuber, 0.5 part of borneol, 1 part of leech, 0.5 part of cuttlebone, 0.5 part of ginseng, Radix Astragali
0.5 part, 0.5 part of gypsum.
Embodiment 2
A kind of externally applied drug that can effectively treat pressure sore, it is characterised in that its effective medicinal components by following parts by weight bulk pharmaceutical chemicals
It is made: 2 parts of Radix Salviae Miltiorrhizae, 2 parts of dragon's blood, 2 parts of myrrh, 2 parts of olibanum, 2 parts of safflower;2 parts of the coptis, 2 parts of cordate houttuynia, 2 parts of Fructus Forsythiae, honeysuckle
2 parts, 2 parts of dandelion, 2 parts of frutus cnidii, 2 parts of corydalis tuber, 0.1 part of borneol, 2 parts of leech, 0.1 part of cuttlebone, 0.1 part of ginseng, Radix Astragali
0.1 part, 0.1 part of gypsum.
Embodiment 3
A kind of externally applied drug that can effectively treat pressure sore, it is characterised in that its effective medicinal components by following parts by weight bulk pharmaceutical chemicals
It is made: 1 part of Radix Salviae Miltiorrhizae, 1 part of dragon's blood, 1 part of myrrh, 1 part of olibanum, 1 part of safflower;2 parts of the coptis, 2 parts of cordate houttuynia, 0.5 part of Fructus Forsythiae, gold and silver
Spend 0.5 part, 0.5 part of dandelion, 0.5 part of frutus cnidii, 0.5 part of corydalis tuber, 0.1 part of borneol, 0.5 part of leech, 0.1 part of cuttlebone, people
Join 0.5 part, 0.5 part of Radix Astragali, 0.1 part of gypsum.
Experimental example
It is accumulative that 50 Patients with Pressure Ulcers is selected to use this medicine, it observes as follows:
1, it diagnoses: with red, swollen, hot, pain local inflammation around the surface of a wound, or even suppurating, stench symptom.
2, usage: 1:10 is mixed with physiological saline, and medicine yarn is made and spreads on affected part, and one time a day, 7 days effective.Treatment time
5-20 days etc..
3, curative effect determinate standard:
Cure: clinical symptoms all disappear.
Effective: clinical symptoms largely disappear.
It is effective: clinical symptom relief.
Invalid: clinical symptoms are not improved or are aggravated.
4, curative effect counts:
(1) it fully recovers: 38, cure rate 76%.
(2) effective: 9, obvious effective rate 18%.
(3) invalid: 3, inefficiency 6%
Total effective rate 94%, therapeutic effect is significant.
It is described above, only a specific embodiment of the invention, it is various to illustrate not content structure for the essence of the present invention
At limitation.
Claims (3)
1. a kind of externally applied drug that can effectively treat pressure sore, it is characterised in that its effective medicinal components by following parts by weight raw material
Medicine is made: 0.5-3 parts of Radix Salviae Miltiorrhizae, 0.5-3 parts of dragon's blood, 0.5-3 parts of myrrh, 0.5-3 parts of olibanum, 0.5-3 parts of safflower;Coptis 0.5-2
Part, 0.5-2 parts of cordate houttuynia, 0.5-2 parts of Fructus Forsythiae, 0.5-2 parts of honeysuckle, 0.5-2 parts of dandelion, 0.5-2 parts of frutus cnidii, corydalis tuber
0.5-2 parts, 0.1-1 parts of borneol, 0.5-2 parts of leech, 0.1-1 parts of cuttlebone, 0.1-1 parts of ginseng, 0.1-1 parts of Radix Astragali, gypsum
0.1-1 parts.
2. the externally applied drug described in accordance with the claim 1 that can effectively treat pressure sore, it is characterised in that by the original of following parts by weight
Material medicine is made: 3 parts of Radix Salviae Miltiorrhizae, 3 parts of dragon's blood, 3 parts of myrrh, 3 parts of olibanum, 3 parts of safflower;1 part of the coptis, 1 part of cordate houttuynia, 1 part of Fructus Forsythiae, gold
1 part of honeysuckle flower, 1 part of dandelion, 1 part of frutus cnidii, 1 part of corydalis tuber, 0.5 part of borneol, 1 part of leech, 0.5 part of cuttlebone, 0.5 part of ginseng,
0.5 part of Radix Astragali, 0.5 part of gypsum.
3. can effectively treat the externally applied drug of pressure sore as claimed in claim 1 or 2, it is characterised in that containing pharmaceutically acceptable auxiliary
Material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910675453.7A CN110302293A (en) | 2019-07-25 | 2019-07-25 | A kind of externally applied drug that can effectively treat pressure sore |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910675453.7A CN110302293A (en) | 2019-07-25 | 2019-07-25 | A kind of externally applied drug that can effectively treat pressure sore |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110302293A true CN110302293A (en) | 2019-10-08 |
Family
ID=68080868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910675453.7A Pending CN110302293A (en) | 2019-07-25 | 2019-07-25 | A kind of externally applied drug that can effectively treat pressure sore |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110302293A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114681527A (en) * | 2020-12-31 | 2022-07-01 | 鼎正新兴生物技术(天津)有限公司 | External application ointment for treating bovine laminitis and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104873851A (en) * | 2015-06-04 | 2015-09-02 | 王星月 | Internal and external traditional-Chinese-medicine composition for treating bedsore |
CN108186840A (en) * | 2018-03-22 | 2018-06-22 | 邓丽丽 | A kind of wound for the treatment of accumulates Chinese medicine ointment of malicious rotten routed pain and preparation method thereof |
-
2019
- 2019-07-25 CN CN201910675453.7A patent/CN110302293A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104873851A (en) * | 2015-06-04 | 2015-09-02 | 王星月 | Internal and external traditional-Chinese-medicine composition for treating bedsore |
CN108186840A (en) * | 2018-03-22 | 2018-06-22 | 邓丽丽 | A kind of wound for the treatment of accumulates Chinese medicine ointment of malicious rotten routed pain and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
许依春: "自拟中药生肌散外敷治疗褥疮150例", 《中国中医药现代远程教育》 * |
郑艺: "中医治疗褥疮40 例的护理体会", 《现代中西医结合杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114681527A (en) * | 2020-12-31 | 2022-07-01 | 鼎正新兴生物技术(天津)有限公司 | External application ointment for treating bovine laminitis and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103230500A (en) | Preparation method of traditional Chinese medicine lotion for treating fever-type felon | |
CN103961552B (en) | A kind of external-applied ointment and preparation method for the treatment of decubital ulcer | |
CN103845578B (en) | Treatment burn and scald, decubital ulcer, herpes zoster external-use tincture and preparation method | |
CN110302293A (en) | A kind of externally applied drug that can effectively treat pressure sore | |
CN105250712B (en) | A kind of Chinese medicine composition for treating bedsore | |
CN101530516B (en) | Chinese medicament for treating appendicitis | |
CN104587206A (en) | Medicament for treating bedsore and preparation method of medicament | |
CN104491642A (en) | Foot bath powder for preventing and treating gout | |
CN101843889A (en) | Medicament for treating lymphedema and venous edema and application thereof | |
CN103251754A (en) | Traditional Chinese medicine composition for treating bedsore | |
CN102698086A (en) | Chinese medicinal emulsion for treating bedsore accumulated toxin decay | |
CN112618626A (en) | Traditional Chinese medicine spray for treating herpes zoster and preparation method thereof | |
CN102824421B (en) | Method for preparing Chinese medicinal lotion for treating surprised type closed fracture | |
CN102526385B (en) | Medicament for treating climacteric syndrome | |
CN101658635B (en) | Chinese medical preparation for treating burn and scald and preparation method | |
CN101637558B (en) | Medicament for treating thrombocytolytic purpura | |
CN110237152A (en) | A kind of externally applied drug that can effectively treat face acnes | |
CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN103349689B (en) | Drug for treating ulcers and sores | |
CN102125612A (en) | Chinese medicinal preparation for treating acute lumbar sprain | |
CN100544756C (en) | A kind of Chinese medicinal soft capsule for the treatment of acute mastitis and preparation method thereof | |
CN101229268A (en) | Retinervus-smoothing regeneration ointment | |
CN105687659A (en) | Medicine patch for treating cesarean-postoperative abdominal incision sclerosis | |
CN105998421A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
CN1265827C (en) | Combination of Chinese traditional medicine for treating disease of cervical erosion, preparation and method of application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191008 |